The CAVE Score for Predicting Late Seizures After Intracerebral Hemorrhage
Overview
Neurology
Authors
Affiliations
Background And Purpose: Seizures are a common complication of intracerebral hemorrhage (ICH). We developed a novel tool to quantify this risk in individual patients.
Methods: Retrospective analysis of the observational Helsinki ICH Study (n=993; median follow-up, 2.7 years) and the Lille Prognosis of InTra-Cerebral Hemorrhage (n=325; 2.2 years) cohorts of consecutive ICH patients admitted between 2004 and 2010. Helsinki ICH Study patients' province-wide electronic records were evaluated for early seizures occurring within 7 days of ICH and among 7-day survivors (n=764) for late seizures (LSs) occurring >7 days from ICH. A Cox regression model estimating risk of LSs was used to derive a prognostic score, validated in the Prognosis of InTra-Cerebral Hemorrhage cohort.
Results: Of the Helsinki ICH Study patients, 109 (11.0%) had early seizures within 7 days of ICH. Among the 7-day survivors, 70 (9.2%) patients developed LSs. The cumulative risk of LSs was 7.1%, 10.0%, 10.2%, 11.0%, and 11.8% at 1 to 5 years after ICH, respectively. We created the CAVE score (0-4 points) to estimate the risk of LSs, with 1 point for each of cortical involvement, age<65 years, volume>10 mL, and early seizures within 7 days of ICH. The risk of LSs was 0.6%, 3.6%, 9.8%, 34.8%, and 46.2% for CAVE scores 0 to 4, respectively. The c-statistic was 0.81 (0.76-0.86) and 0.69 (0.59-0.78) in the validation cohort.
Conclusions: One in 10 patients will develop seizures after ICH. The risk of this adverse outcome can be estimated by a simple score based on baseline variables.
Wang Z, Xu H, Liu J, Lin R, He D, Yang Y Quant Imaging Med Surg. 2025; 15(2):1175-1189.
PMID: 39995708 PMC: 11847184. DOI: 10.21037/qims-24-1345.
Risk factors of posthemorrhagic seizure in spontaneous intracerebral hemorrhage.
Imsamer A, Sitthinamsuwan B, Tansirisithikul C, Nunta-Aree S Neurosurg Rev. 2025; 48(1):76.
PMID: 39847089 PMC: 11757938. DOI: 10.1007/s10143-025-03229-2.
Frontera J, Rayi A, Tesoro E, Gilmore E, Johnson E, Olson D Neurocrit Care. 2024; 42(1):1-21.
PMID: 39707127 DOI: 10.1007/s12028-024-02183-z.
Yamada S, Nakagawa I, Kotsugi M, Asada K, Kasahara M Methods Protoc. 2024; 7(5).
PMID: 39452793 PMC: 11510630. DOI: 10.3390/mps7050079.
Seizure prophylaxis in pneumococcal meningitis, cohort study.
Guillem L, Hernandez-Perez G, Berbel D, Pelegrin I, Falip M, Cabellos C Epilepsia Open. 2024; 9(6):2319-2330.
PMID: 39348192 PMC: 11633693. DOI: 10.1002/epi4.13054.